BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21448897)

  • 1. An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program.
    Wilsey BL; Fishman SM; Gilson AM; Casamalhuapa C; Baxi H; Lin TC; Li CS
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1262-8. PubMed ID: 21448897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid prescription patterns among patients who doctor shop; Implications for providers.
    Schneberk T; Raffetto B; Friedman J; Wilson A; Kim D; Schriger DL
    PLoS One; 2020; 15(5):e0232533. PubMed ID: 32453745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple prescribers in older frequent opioid users--does it mean abuse?
    Neutel CI; Skurtveit S; Berg C; Sakshaug S
    J Popul Ther Clin Pharmacol; 2013; 20(3):e397-405. PubMed ID: 24201229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Supply of Prescription Opioids: Contributions of Episodic-Care Prescribers and High-Quantity Prescribers.
    Schneberk T; Raffetto B; Kim D; Schriger DL
    Ann Emerg Med; 2018 Jun; 71(6):668-673.e3. PubMed ID: 29275945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Doctor and pharmacy shopping": A fading signal for prescription opioid use monitoring?
    Delcher C; Harris DR; Park C; Strickler GK; Talbert J; Freeman PR
    Drug Alcohol Depend; 2021 Apr; 221():108618. PubMed ID: 33677354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.
    Cepeda MS; Fife D; Chow W; Mastrogiovanni G; Henderson SC
    Drug Saf; 2012 Apr; 35(4):325-34. PubMed ID: 22339505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use.
    Young SG; Hayes CJ; Aram J; Tait MA
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1117-1124. PubMed ID: 31168860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids.
    Chua KP; Brummett CM; Conti RM; Haffajee RL; Prosser LA; Bohnert ASB
    JAMA Netw Open; 2019 May; 2(5):e193673. PubMed ID: 31074819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
    Chang HY; Murimi IB; Jones CM; Alexander GC
    Addiction; 2018 Apr; 113(4):677-686. PubMed ID: 29193546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
    Guy GP; Zhang K; Halpin J; Sargent W
    Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.
    Hinami K; Ray MJ; Doshi K; Torres M; Aks S; Shannon JJ; Trick WE
    J Gen Intern Med; 2019 Nov; 34(11):2443-2450. PubMed ID: 31420823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
    Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
    Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
    South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing trends in Schedule II opioid use and doctor shopping during 1999-2007 in California.
    Han H; Kass PH; Wilsey BL; Li CS
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):26-35. PubMed ID: 23956137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers ("doctor shopping").
    McDonald DC; Carlson KE
    Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1258-67. PubMed ID: 25111716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use.
    Barnett ML; Olenski AR; Jena AB
    N Engl J Med; 2017 Feb; 376(7):663-673. PubMed ID: 28199807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.